Esomeprazole Magnesium Capsule, Delayed Release Pellets
Product Images NDC 50090-6128

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 50090-6128). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure2.jpg (Figure2)

A line graph depicting the percent of individuals maintaining a condition over a six-month period. It compares four groups: Esomeprazole Magnesium 40 mg, 20 mg, 10 mg, and a placebo. The x-axis represents time in months from 0 to 6, while the y-axis shows percent maintained from 0 to 100. The 40 mg dosage maintains the highest percentage over time, followed by 20 mg, 10 mg, and placebo with the lowest retention.*

FDA Label Image

Figure3.jpg (Figure3)

A line graph showing the percent maintained over a 6-month period for Esomeprazole Magnesium at doses of 40 mg, 20 mg, 10 mg, and a placebo. The y-axis represents percent maintained from 0 to 100%, and the x-axis represents months from 0 to 6. The graph includes four plotted lines comparing the effectiveness of the different doses versus placebo over time.*

FDA Label Image

Figure4.jpg (Figure4)

Line chart depicting the percent of patients symptom-free over 28 days, comparing Esomeprazole Magnesium 40 mg, Esomeprazole Magnesium 20 mg, and placebo. The x-axis represents diary days from 0 to 28, and the y-axis shows percent of patients symptom-free from 0 to 100. The chart shows increasing symptom-free percentages over time, with 40 mg generally higher than 20 mg, and placebo the lowest.*

FDA Label Image

Figure5.jpg (Figure5)

A line graph showing the percentage of patients symptom-free over 28 diary days, comparing three groups: Esomeprazole Magnesium 40 mg, Esomeprazole Magnesium 20 mg, and Placebo. The graph illustrates trends of symptom relief for each group across the study period.*

FDA Label Image

Logo (Image 01)

FDA Label Image

Label Image (Lbl500906128)

Label for Esomeprazole Magnesium 40 mg capsules, delayed-release pellets, oral route, supplied by A-S Medication Solutions. The label includes dosage instructions, storage conditions to keep between 60 and 77 degrees Fahrenheit, package count of 90 capsules, and relevant NDC and lot numbers.*

FDA Label Image

Logo (Logo)

FDA Label Image

Structure (Structure)

Chemical structure diagram of esomeprazole magnesium, showing the molecular components and hydrated form typical of this compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.